INTRODUCTION
Macrophages are versatile and plastic cells that have the ability to fuse and give rise to multinucleate cells (Chen and Olson, 2005) . Macrophage fusion leads to the formation of osteoclasts in bone and multinucleate giant cells (MGCs) in chronic inflammatory diseases (Brodbeck and Anderson, 2009; Helming and Gordon, 2009; Vignery, 2005) . Thus, both osteoclasts and MGCs are derived from the fusion of macrophages. Multinucleation represents an essential step in osteoclast formation and activation because mononucleate osteoclasts are unable to resorb bone efficiently (Helming and Gordon, 2009; Vignery, 2005 Vignery, , 2008 and the genes that are critical for osteoclast activity are also fundamental to MGC function (Bü hling et al., 2001; da Costa et al., 2005; Yagi et al., 2005; Zhu et al., 2007) . Despite the well-characterized role of osteoclasts in bone homeostasis, macrophage activation associated with MGC formation in inflammatory diseases remains poorly understood.
Genetic studies in mice and humans suggest that germline sequence variation can regulate macrophage multinucleation and that this can influence disease pathogenesis. In a murine model of chronic tuberculosis infection, genetic loci were associated with production of inflammatory mediators by macrophages (Kramnik et al., 2000; Pichugin et al., 2009) , suggesting the presence of a heritable genetic component affecting MGC function, which, in turn, mediates susceptibility to granulomatous diseases. In humans, deletions or loss-of-function mutations in either the TYROBP (DAP12) or TREM2 genes are causally associated with Nasu-Hakola disease (Paloneva et al., 2000 (Paloneva et al., , 2002 , where defective multinucleation in osteoclasts results in impaired bone resorption (Humphrey et al., 2004) . In addition, human genome-wide association studies of MGC-associated diseases such as tuberculosis (Thye et al., 2012) and granulomatosis with polyangiitis (Lyons et al., 2012) identified common sequence variations associated with these disorders. In rheumatoid arthritis (RA), osteoclast differentiation and activation lead to bone erosion associated with prolonged inflammation (McInnes and Schett, 2011) . However, to date, genetic studies failed to identify genes and pathways involved in osteoclast activation resulting from multinucleation. Hence, the key determinants and molecular pathways of multinucleation in macrophages and the resulting pathophysiological effects remain largely unexplored.
RESULTS

Identification of a Multinucleation Gene Network in Macrophages
In order to investigate the genetic components of MGC formation, we took advantage of strain-specific phenotypic differences in spontaneous formation of MGCs in the rat, which have not been described previously. We observed that when bonemarrow-derived macrophages (BMDMs) from Wistar Kyoto (WKY) rats and Lewis (LEW) rats are cultured in vitro, WKY macrophages spontaneously form MGCs in contrast with what is observed in LEW ( Figures 1A and S1 ). These strains have been widely studied for their differential susceptibility to experimental glomerulonephritis through macrophage activation (Aitman et al., 2006; Behmoaras et al., 2008 Behmoaras et al., , 2010 Page et al., 2012) , and WKY rats also show MGCs in their glomeruli following the induction of nephrotoxic nephritis (NTN) ( Figure S1 ). These marked phenotypic differences suggested genetic determinants of the process underlying MGC formation in the rat, which we set out to investigate by profiling genome-wide expression levels in macrophages of 200 backcross rats derived from WKY and LEW.
We used mRNA expression level as a quantitative trait to carry out genome-wide linkage analysis using a panel of single nucleotide polymorphisms (SNPs) throughout the rat genome. Using multivariate Bayesian regression approaches (Bottolo et al., 2011b) , we identified a set of 2,357 transcripts showing significant linkages to discrete genetic loci (posterior probability >80%), which are designated as expression quantitative trait loci (eQTLs, Figure S2 ). The majority of transcripts were regulated by local genetic variation forming cis-eQTLs (67%); however, we also identified many trans-regulated transcripts (trans-eQTLs) across the rat genome ( Figure 1B ). As previously reported (Hubner et al., 2005; Langley et al., 2013) , trans-eQTLs can form clusters that are commonly referred to as trans-eQTLs hot spots (Breitling et al., 2008) (Table 1) . Notably, we identified a large eQTL hot spot that mapped to three SNPs spanning a genomic region of 1.2 Mbp located on rat chromosome 9q11, which regulated in trans the expression of 190 transcripts (Table 1; Figure 1B ). These 190 transcripts formed a gene coexpression network, where each gene is regulated in trans by the same genetic locus ( Figure 1C ). Cell-type enrichment analysis using a mouse gene expression atlas showed that the gene network is enriched for osteoclast genes (enrichment p value = 4 3 10 À7 , Z test for relative overexpression of the network genes in a tissue/cell type, see Supplemental Experimental Procedures), suggesting a role for the network in macrophage multinucleation ( Figure 1C ). Closer inspection of the network genes revealed two major determinants of osteoclast activity (Mmp9 and cathepsin K, reviewed in Helming and Gordon, 2009 ) as well as several reported regulators of macrophage multinucleation such as P2rx7 (Lemaire et al., 2006) , Tm7sf4 (also known as DC-STAMP [Yagi et al., 2005] ), osteopontin (Osp) (Tsai et al., 2005) , Pik3cb (also known as PI3K [Peng et al., 2010] ), tetraspanin Cd9 (Takeda et al., 2003) , and its binding partner Igsf8.
We hypothesize that other genes of the large coexpression network might regulate macrophage multinucleation, therefore defining a ''Macrophage Multinucleation Network'' or MMnet.
To prioritize master regulator genes at the rat chromosome 9 locus, we carried out fine mapping analysis and, among others, identified the Triggering receptor expressed in myeloid cells (Trem) gene family cluster within the 2-LOD drop support interval of the peak of linkage ( Figure 1D ). At this locus, the Trem family genes showed the strongest cis-acting genetic regulation in macrophages (variation in gene expression explained by the regulatory locus; R 2 > 0.25, Figures 1E) , and, among all genes in the MMnet, Kcnn4 was the most significant trans-eQTL ( Figure 1E ). Quantitative real-time PCR analysis of the expression of the Trem family genes in backcross macrophages confirmed their cis-regulation and prioritized Trem2 as the most highly expressed gene in rat macrophages (>90-fold more expression compared to all other genes in the Trem cluster, Figure 1F ).
Identification of Trem2 as a Master Genetic Regulator of the MMnet
We observed a positive correlation between the expression of Trem2 and 125 (66%) MMnet genes and a negative correlation between Treml1, D3ZDX3_Rat, Treml2, and the network genes ( Figure 2A ). We selected ten genes from the MMnet, including the most strongly trans-regulated gene (Kcnn4, R 2 = 0.25), genes previously reported to play a role in macrophage multinucleation (P2rx7 [Lemaire et al., 2006] , Tm7sf4 [Yagi et al., 2005] , Pik3cb [Peng et al., 2010] , tetraspanin Cd9 [Takeda et al., 2003] ) and additional trans-regulated MMnet genes with varying genetic effects (R 2 ranging from $0.1 to 0.22). These genes recapitulate the correlation pattern observed between the Trem cluster genes and the MMnet ( Figure 2B ). We carried out RNAi experiments to further prioritize candidates within the Trem gene cluster as potential master regulators of the MMnet, by using small interfering RNA (siRNA) against Treml1, Trem2, D3ZDX3_Rat, and Treml2 genes that were differentially expressed between WKY and LEW macrophages ( Figure 1F ), followed by quantitative realtime PCR assessment of ten trans-regulated genes from the network. In keeping with the positive correlation between Trem2 and the MMnet genes ( Figures 2A and 2B ), we found significant downregulation of the trans-regulated genes after Trem2 silencing ( Figure 2C ). On the contrary, silencing of Treml1, D3ZDX3_Rat, and Treml2 resulted in a weaker and variable downregulation of the network genes ( Figure 2C ). This downregulation was not in accordance with the expected transcriptional response based on the negative correlation between Treml1, D3ZDX3_Rat, Treml2, and each trans-eQTL gene expression ( Figure 2B ). These in vitro experiments prioritized Trem2 as a master regulator gene of the MMnet in the rat. We then explored whether silencing of TREM2 in monocyte-derived macrophages had a similar effect on the trans-eQTL network genes in humans ( Figure 2D ). We showed that there was a significant correlation between the percentage of knockdown in human MDMs and rat BMDMs following Trem2 knockdown ( Figure 2E ). These data suggest that the Trem2-regulated MMnet genes identified in rat macrophages are similarly regulated in human macrophages. Taken together, genome-wide eQTL analysis and in vitro experiments uncovered a large gene network regulating macrophage multinucleation, which is under trans-acting genetic control by the Trem2 gene in rats and humans.
Kcnn4 Is Implicated in Macrophage Multinucleation in Rodents and Humans
Because multinucleate osteoclasts and MGCs originate from macrophages (Vignery, 2005) , our data suggest that MMnet controlled by Trem2 may contain novel genes regulating macrophage multinucleation. We therefore hypothesized that the most significant trans-eQTL in the network (R 2 = 0.25, p = 3.8 3 10 À16 , Figure 1E ), Kcnn4, encoding an intermediate-conductance calcium-activated potassium channel, regulates multinucleation in macrophages. Kcnn4 expression peaked during macrophage multinucleation ( Figure S3 ) and a separate time-dependent microarray analysis of fusing rat alveolar macrophages and human monocytes revealed Kcnn4 as a differentially expressed gene, which is strongly induced at the onset of fusion ( Figure S3 ). We therefore investigated whether Kcnn4 determines multinucleation in osteoclasts and MGCs, two cell types resulting from multinucleation in physiological and pathological conditions, respectively. To this aim, we used two selective distinct pharmacological blockers (ICA-17043 and TRAM-34) of Kcnn4 in human and rodent osteoclasts and MGCs and confirmed the effect of these blockers with targeted gene deletion and RNAi for Kcnn4 (Figure 3 ). Transfection with siRNA designed against Kcnn4 (Figure 3A) , selective pharmacological blockade (Figures 3B and 3D) , and targeted gene deletion ( Figure 3C ) of Kcnn4 consistently decreased macrophage multinucleation in rodents. Similar results were obtained in human osteoclasts and MGCs ( Figures  3E and 3F ), indicating that Kcnn4 regulates macrophage multinucleation in rodents and humans. The inhibitory effect of TRAM-34 on macrophage multinucleation is reversible and TRAM-34 does not affect macrophage differentiation ( Figure S3 ) but changes the macrophage transcriptome assessed by highthroughput sequencing of mRNA (RNA-seq, Figure S3 ). Furthermore, in order to assess whether the absence of Kcnn4 affects preosteoclast formation, we have quantified TRAP + mononuclear cells isolated from Kcnn4 +/+ and Kcnn4 À/À mice at day 3, 4, and 5 of cell differentiation and showed that early steps of osteoclast differentiation do not seem to be affected by Kcnn4 deficiency ( Figure S3 ).
Kcnn4
Modulates Bone Turnover Given our data implicating Kcnn4 in macrophage multinucleation and because defects in osteoclast formation impact bone resorption (Teitelbaum, 2011) , we tested whether Kcnn4 deficiency affects bone mass. Femurs from Kcnn4 +/+ and Kcnn4 À/À female and male mice were analyzed by X-ray, peripheral quantitative computed tomography (pQCT), and microcomputed tomography (microCT). These analyses consistently revealed increased bone mass and density in both female and male Kcnn4 À/À mice compared with Kcnn4 +/+ mice ( Figure 4 ).
In particular, femurs from Kcnn4 À/À mice showed increased (1) X-ray absorption ( Figure 4A ), (2) total bone mineral density (9% and 14% increases in females and males, respectively), (3) trabecular bone density (30% and 29% in females and males), and (4) trabecular bone volume fraction (27% and 26% in females and males) (Figures 4B and 4C mice lacked the normal osteoclast-mediated bone resorption response to inflammation ( Figure 4E ). We also showed that deletion of Kcnn4 results in reduced osteoclastic resorption in vitro ( Figure S4 ). Taken together, these data indicate that Kcnn4 participates in the control of bone turnover by regulating functional osteoclast formation and suggest that its effects on bone formation may be mediated via a primary role in osteoclasts.
Inactivation of Kcnn4 Reduces Severity of Glomerulonephritis and Bone Erosion in Arthritis
To study the role of Kcnn4 in macrophage multinucleation in pathological conditions, we used two inflammatory models in rodents, characterized by MGC and osteoclast activation: glomerulonephritis and arthritis, respectively. In crescentic glomerulonephritis (Crgn), we blocked Kcnn4 with its selective inhibitor TRAM-34 (Wulff et al., 2000) in the WKY NTN model characterized by glomerular MGCs ( Figure S1 ; Lan et al., 1998) . In the WKY NTN model, the severe and reproducible glomerular macrophage infiltration following nephrotoxic serum injection (Tam et al., 1999) is also characterized by approximately 20% of glomeruli presenting MGCs (Figures 5 and S1). It is therefore possible to study the effect of TRAM-34 on glomerular MGC formation and renal injury assessed by proteinuria. TRAM-34 treatment of WKY rats with NTN led to significant reduction of glomerular crescents, glomerular MGC formation, and proteinuria without affecting the number of macrophages infiltrating the glomeruli ( Figures 5A and 5B (Takayanagi, 2007) , and, consistent with this, there was reduced expression of NFATc1 in Kcnn4 À/À osteoclasts ( Figure 6C ). The reduced NFATc1 expression was associated with decreased nuclear translocation in Kcnn4 À/À bonemarrow-derived macrophages in response to RANKL (Figure 6D) . Similarly, WKY BMDMs treated with TRAM-34 exhibit reduced Nfatc1 expression associated with decreased multinucleation (data not shown). To elucidate the mechanisms by which Kcnn4 affects osteoclast differentiation, we stimulated macrophages with RANKL or LPS for increasing time periods and found that RANKL-induced p38 and ERK activation were not modified by Kcnn4 deficiency (data not shown). In contrast, RANKL-induced Akt activation was reduced ( Figure S6 ). This result was confirmed in human macrophages treated with TRAM-34 ( Figure S6 ). Because Akt has been shown to be a (E) Human-monocyte-derived macrophages were cultured in Lab-Tek chambers, and spontaneous MGC formation was observed in some buffy coats, and this was significantly reduced when cells were incubated with TRAM-34 (10 mM). At least three separate buffy coats were used to differentiate human macrophages. Original bars, 50 mm. p < 0.001 determined by Kruskal-Wallis test. (F) Human peripheral blood monocytes were cultured in the presence of M-CSF (20 ng/ml) and RANKL (10 ng/ml) for 5 days to induce the differentiation of osteoclasts. Cells were treated with TRAM-34 or ICA-17043 (both 10 mM, left panel). Quantification of osteoclast number per well shows that TRAM-34 and ICA-17043 inhibited the formation of monocyte-derived human osteoclasts in a dose-dependent manner (mean ± SD; n = 4). Original bars, 100 mm. See also Figure S3 . critical mediator of cell proliferation and survival in a variety of cell types (Scheid and Woodgett, 2001) , our results showing impaired Akt phosphorylation in association with Kcnn4 deficiency suggested that Kcnn4 may regulate apoptosis. Supporting this hypothesis, deletion of Kcnn4 was associated with increased apoptosis in osteoclasts ( Figure S6 ).
DISCUSSION
Using systems genetics approaches, our study demonstrates how genomic sequence variation affects a unique regulatory network that is associated with macrophage multinucleation in the rat. By conducting an eQTL study in the primary macrophages of a backcross rat population derived from two inbred rat strains with contrasting phenotypes (''markedly fusogenic WKY macrophages'' versus ''lowly fusogenic LEW macrophages''), we have identified a unique gene regulatory network (MMnet) associated with macrophage multinucleation in the rat. We show that Trem2 regulate MMnet, which was enriched for genes regulating osteoclast formation in the rat, a result that was confirmed in human macrophages. Consistent with the previously established role of Trem2 in macrophage fusion (Helming et al., 2008) , activation (Turnbull et al., 2006) , and osteoclast formation (Cella et al., 2003; Humphrey et al., 2006; Otero et al., 2012) , here, we demonstrate that the strongest trans-eQTL in the Trem2-controlled gene network, Kcnn4, is a key determinant of macrophage multinucleation in rodent and human osteoclasts and MGCs. We independently confirmed the role of Kcnn4 as a potential modulator of multinucleation by microarray analysis of fusing rat macrophages and human monocytes that form osteoclasts. We show that Kcnn4 inhibitors prevent the formation of monocyte-derived human osteoclasts and MGCs, in addition to mouse bone-marrow-derived osteoclasts and rat MGCs.
Kcnn4 (also known as Kca3.1 or IK1) is activated in response to increases in intracellular Ca 2+ through calmodulin bound to its intracellular C terminus (Lam and Wulff, 2011) . The blockade of this channel by a selective small molecule inhibitor (TRAM-34) was first shown to have immunosuppressive effects on T lymphocytes (Wulff et al., 2000) and further tested on T cellmediated diseases such as inflammatory bowel disease, experimental autoimmune encephalomyelitis, rheumatoid arthritis, and asthma (reviewed in Lam and Wulff [2011] ). Although Kcnn4 is expressed in macrophages, its role in macrophage multinucleation has not previously been reported. Treatment with TRAM-34 improved atherosclerosis in ApoE À/À mice aortas and carotid arteries by decreasing macrophage infiltration and by possibly inhibiting their migration (Toyama et al., 2008) . Similarly, TRAM-34 treatment reduced ED1 + macrophages and microglia in the rat brain following ischemia/reperfusion stroke (Chen et al., 2011b) , and, more recently, it has been shown that blockade of Kcnn4 reduced F4/80 + cells in a streptozotocin-induced diabetic mouse model (Huang et al., 2013) . Although it had been reported that Ca
2+
-activated K + currents are involved in the regulation of osteoclast movement and spreading on bone substrates, and that increase in intracellular Ca 2+ blocks osteoclast bone resorption in vitro (Valverde et al., 2005) , the specific contribution of Kcnn4 in inflammationinduced osteoclast development in vivo was not previously reported. The effect of Kcnn4 on bone mass is modest compared to its critical regulatory role in osteoclast and macrophage multinucleation. This is consistent with previous findings demonstrating a relatively mild effect of macrophage fusion marker (DC-STAMP) on bone mass (Yagi et al., 2005) . At this stage, the bone formation abnormality observed in Kcnn4 À/À mice remains incompletely understood and additional studies to investigate further will require detailed analysis of Kcnn4 +/+ and Kcnn4 À/À mice at various ages during development and adulthood, as well as cell-specific gene targeting approaches because it was previously used for studying the effect of cathepsin-k deletion on bone formation (Lotinun et al., 2013) . We also show that Kcnn4 affects macrophage multinucleation without having an effect on preosteoclast formation, a result previously documented for Atp6v0d2, a regulator of osteoclast fusion (Lee et al., 2006) . Here, we show that Kcnn4-deficient mice fail to mount an osteoclastic response to local injection of LPS into calvaria. Local osteoclast formation and bone loss are a major component of the pathogenesis of metabolic and inflammatory bone diseases (Boyle et al., 2003) . Thus, Kcnn4, which was previously reported as a potential target for immunosuppression (Cahalan and Chandy, 1997; Jensen et al., 2001) , autoimmune diseases (Wulff et al., 2003) , and periodontal disease (Valverde et al., 2005) , also represents a potential new target for the prevention of inflammation-related bone loss.
The WKY NTN model of Crgn is characterized by glomerular MGC formation (Kaneko et al., 2003) and the renal injury is entirely dependent on macrophage infiltration and activation +/+ and Kcnn4 À/À female and male mice. Note the stronger radio-opacity in femurs from Kcnn4 À/À mice when compared with Kcnn4 +/+ mice.
(B) Peripheral quantitative computed tomography (pQCT) analysis of femoral bones showing total bone density and trabecular bone density of distal femurs from 8-week-old Kcnn4 À/À mice compared with Kcnn4 +/+ mice (mean ± SD; n = 7-9).
(C) Representative images of microcomputed tomography (microCT) analysis of distal femurs (left panel) from 8-week-old female and male Kcnn4 +/+ and Kcnn4 À/À mice. Trabecular bone volume fraction from Kcnn4 +/+ and Kcnn4 À/À female and male mice is shown in the right panel (mean ± SD; n = 7-9).
(D) Histomorphometry analysis of tibiae from 8-week-old Kcnn4 +/+ and Kcnn4 À/À female and male mice showing the number of osteoclasts per trabecular bone perimeter (mean ± SD; n = 10).
(E) Microcomputed tomography analysis of calvaria from 8-week-old Kcnn4 À/À and Kcnn4 +/+ male and female mice that had received a 2 ml of injection of 25 mg LPS on the right calvaria. Mice were sacrificed 5 days later. Note the low abundance of resorption lacunae in Kcnn4 À/À mice when compared with wild-type.
Calvarial bone volume fraction, bone thickness and bone density were higher, whereas bone surface density was lower in Kcnn4 À/À mice when compared with wild-type (right panel; mean ± SD; n = 5). See also Figure S4 and Table S1 . (C) Collagen antibody-induced arthritis (CAIA) was induced in 2-month-old male and female Kcnn4 À/À and Kcnn4 +/+ mice (mean ± SD; n = 12-15). Arthritic severity was monitored daily using a visual scoring system as detailed in Supplemental Experimental Procedures. Based on inflammation scoring, Kcnn4 deletion (legend continued on next page) (Aitman et al., 2006; Behmoaras et al., 2008 Behmoaras et al., , 2010 D'Souza et al., 2013; Deplano et al., 2013; Hull et al., 2013; Page et al., 2012) . We show that blocking Kcnn4 in vivo by administration of TRAM-34 significantly reduces glomerular injury in the WKY NTN model. Although we did not observe different numbers of glomerular macrophages between TRAM-34 and vehicletreated animals, there was a reduction in glomerular MGCs, which suggests that Kcnn4 blockade reduced multinucleation in vivo by preventing disease. In keeping with this, we show that Kcnn4 deletion leads to a reduced severity in chronic inflammatory arthritis characterized by osteoclast activation. Collagen-induced arthritis is characterized by focal collections of osteoclasts at sites of bone destruction, and previous reports showed that osteoclast depletion ameliorated bone erosion in this model (Romas et al., 2002; Sims et al., 2004 In summary, using a systems genetics approach, we identified a trans-regulated multinucleation network in macrophages and provided compelling evidence that at least one gene within the network (Kcnn4) regulates macrophage multinucleation in bone homeostasis. We also show that Kcnn4 can be effectively targeted to decrease severity of inflammatory conditions characterized by MGC or osteoclast activation.
EXPERIMENTAL PROCEDURES
Animals, Genetic Crosses, and Genotyping Wistar-Kyoto (WKY/NCrl) rats and Lewis (LEW/Crl) were purchased from Charles River UK. Two hundred Backcross (BC) rats were produced by breeding WKY with LEW rats (congenic WKY rats were used where the previously identified crescentic glomerulonephritis QTLs on chromosome 13 and 16 were introgressed from the LEW rats [Behmoaras et al., 2010] ). The (WKY x LEW) F1 animals were backcrossed to the congenic WKY rats. For genotyping, DNA was isolated from the BC rat spleens using a standard phenol-chloroform extraction. DNA (250 ng) was used for NspI and StyI fragmentation according to Affymetrix SNP6.0 GeneChip instructions. Custom designed Whole Genome Rat Genotyping arrays (RATDIV arrays, MDC) that contain 803,484 SNPs covering the rat genome (based on Rn3.4 version) were used. SNP calling was performed using the BRLMM algorithm and led to the identification of 785,247 SNPs with >95% call rate (see Supplemental Experimental Procedures for additional details). Kcnn4 À/À mice were generated on a mixed 129J/C57BL6 background, bred, and genotyped as previously described (Begenisich et al., 2004) . The animals were housed in standard caging on a 12-hr-light cycle and were offered free access to rodent chow (Harlan Teklad #2018 Rodent Diet) and water.
Bone X-Ray Radiography, pQCT, microCT, and Histomorphometry in Mice Excised femurs were subjected to X-ray using a MX-20 (Faxitron X-ray) at 30 kV for 3 s. X-ray films were scanned using an Epson Perfection 4870. Bone density was determined as described previously (Ballica et al., 1999) by Peripheral Quantitative Computed Tomography (pQCT, XCT Research M; Norland Medical Systems) of a virtual 1 mm cross-section of the distal femur 0.25 mm proximal to the growth plate. In addition, distal femurs were scanned with a Microcomputed Tomography (microCT) scanner (MicroCT 40; Scanco) with a 2,048 3 2,048 matrix and isotropic resolution of 12 mm 3 voxel size. 3D trabecular measurements in the secondary spongiosa were made directly, as previously described (Li et al., 2005) . Femurs and tibiae from Kcnn4 +/+ and Kcnn4 À/À mice were dehydrated in a graded ethanol series and embedded without decalcification in methylmethacrylate, as we described previously (Baron et al., 1984) . Four-micrometer-thick cross-sections of the distal femur were stained with Villanueva Mineralized Bone Stain for static histomorphometric analysis (see Supplemental Experimental Procedures), whereas 8-mm-thick sections were left unstained for dynamic bone histomorphometric parameters. All procedures were approved by the Yale University Institutional Animal Care and Use Committee. The care and treatment of experimental mice complied with all applicable federal guidelines and was approved by the Institutional Animal Care and Use Committee at Yale University.
Microarray Expression Profiling, eQTL Mapping, and Network Analysis Total RNA was extracted from BMDMs from 200 backcross rats using TRIzol (Invitrogen), and gene expression was measured using Affymetrix 1.0 ST Rat Gene array. WKY-LEW next-generation sequencing data (Illumina Hiseq 2000) was used to remove SNP-containing probes prior to normalization. Arrays were normalized using RMA normalization from the Affymetrix package (Irizarry et al., 2003) . Normalization step included Norm-exp background correction and quantile normalization. Probes signal were summarized at a transcript level using median polish. The resulting data were log transformed ( Figure S2 ). Remaining batch effects were removed using ComBat (Chen et al., 2011a; Johnson et al., 2007) with nonparametric prior. All other parameters were left to default. The first two principal components of the normalized data before and after correcting for batch effects are shown in Figure S2 . The eQTL mapping was performed using ESS++ (Bottolo et al., 2011a (Bottolo et al., , 2011b . Fixed effects on each individual were added as covariates in the variable selection process to account for potential outliers or genotyping errors. eQTL analysis details, network inference, and cell-type enrichment analysis are described in Supplemental Experimental Procedures.
Nephrotoxic Nephritis in Rats and Collagen Antibody-Induced Arthritis in Mice
The effect of TRAM-34 on nephrotoxic nephritis (NTN) in the WKY rat was assessed as follows: eight male WKY rats were injected with the nephrotoxic serum (NTS) as previously described (D'Souza et al., 2013) . A group of four rats received intraperitoneal injections of TRAM-34 (40 mg/kg) in Miglyol 812 reduced inflammation in males and females, though the prevention was more efficient in female mice. From day 8 onward, the CAIA mean score is significantly different between Kcnn4 +/+ and Kcnn4 À/À animals for both genders (p < 0.001).
(D) Histopathomorphometry analysis of the paws and the ankles of Kcnn4 +/+ and Kcnn4 À/À naive and CAIA-induced female mice. All the histomorphometric parameters (inflammation, pannus, cartilage damage, and bone damage) were compared to CAIA Kcnn4 +/+ mice and are significant (mean ± SEM; n = 10-12 mice in each group; p < 0.05). Similar results were obtained in male mice (data not shown). See also Figure S5 . neutral oil (Kemcare) at 1 ml/g, twice a day with 10 hr intervals for 7 days. The control group (n = 4) had IP injections of Miglyol (vehicle). Rats were killed 7 days following injection of NTS, and glomerular crescents and proteinuria were measured as previously described (D'Souza et al., 2013) . Chronic inflammatory arthritis was induced in 8-week-old male and female Kcnn4 +/+ and Kcnn4 À/À mice by intraperitoneal (i.p.) injection of 7 mg (700 ml) of Arthrogen monoclonal antibodies (ArthoMAB) blend (Millipore) on day 0. This cocktail of monoclonal antibodies is directed against epitopes recognized in the region CB11 of collagen type II. On day 3, 50 mg (<100 ml volume) of LPS was administered i.p. Beginning on day 4, the animals were monitored daily for the onset and development of collagen-antibody-induced arthritis (CAIA), and the injection site on each animal was evaluated for signs of infection, such as heat, redness, and/or exudation. Mice that felt as ''cold,'' which likely underwent cachexia in response to LPS, received subcutaneous injection of 500 ml of warm Ringer solution. Arthritic severity was monitored daily using a visual scoring system (Supplemental Experimental Procedures). The histopathological evaluation of CAIA is described in Supplemental Experimental Procedures.
ACCESSION NUMBERS
The ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) accession number for the rat-bone-marrow-derived macrophage microarray data reported in this paper is E-MTAB-2719. of À20 mV to +80 mV (mean ± SD, *p < 0.05; n = 10), with the exception of Kcnn4 +/+ + ICA-17043 at + 60 mV (mean ± SD, p = 0.06; n = 10) and +80 (mean ± SD, p = 0.11; n = 10). There was no significant difference between Kcnn4 À/À macrophages and Kcnn4 +/+ treated with ICA-17043.
SUPPLEMENTAL INFORMATION
(C) NFATc1 protein levels in BMDMs from Kcnn4 +/+ and Kcnn4 À/À mice. BMDMs isolated from Kcnn4 +/+ and Kcnn4 À/À mice were cultured in the presence of M-CSF (25 ng/ml) and RANKL (40 ng/ml) and subjected to western blot analysis at the indicated times using antibodies directed against NFATc1. GAPDH served as an internal control for equal loading of proteins on a SDS-PAGE protein gel. Note the lower abundance of NFATc1 in Kcnn4 À/À macrophages compared with Original bars, 100 mm. See also Figure S6 .
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Genotype cleaning and imputation
The distribution of haplotype length shows a great overrepresentation of single SNP haplotypes. This overrepresentation can be attributed to genotyping errors that occur randomly in an independent manner. Thus isolated single SNP haplotype are likely to be caused by genotyping errors rather than true recombination events. Therefore, we reversed the genotype calling for all single SNP haplotype surrounded by 2 haplotypes of length greater than 2 or for all cluster of several single SNP haplotype separated by one SNP each and surrounded by 2 haplotypes of length greater than 2. An example of the genotype Imputation and cleaning process can be seen of Figure S2 (panel C).
The WKY and LEW whole genome sequence data (Illumina HiSeq 2000; at least 10X coverage for both strains as described in (Atanur et al., 2013) ) was then used to define the WKY and LEW allele at each individual SNP. SNPs where the WKY and LEW alleles could not be determined from the sequencing data were discarded resulting in 278,124 SNPs that can discriminate both alleles. Frequency of the WKY and LEW alleles across the whole genome can be seen in Figure S2 Missing genotypes were then imputed using fastPhase with the 2 founder haplotypes ( Figure   S2 ). The total number of SNPs for eQTL analysis were 1,974 following removal of those in complete linkage disequilibrium (r 2 =1). The distribution of Identity by Sharing (IBS) was verified in all BC animals and confirmed the absence of any population structure (shown in Figure S2 , panel E).
Primary macrophage, osteoclast cultures and assessment of cell multinucleation
Rat bone marrow derived macrophages (BMDMs) were cultured as previously described (Behmoaras et al., 2010) . BMDMs were flushed from femur and tibia bones from rats and cultured in presence of L929-conditioned media for 4 days. To assess spontaneous MGC formation, macrophages were first dissociated using non enzymatic cell dissociation buffer (Sigma) and re-plated in Lab-Tek chambers (Fisher Scientific, UK). MGCs were then fixed at day 5 using Reastain Quick Diff and MGC quantification was performed by counting the number of nuclei in 100 macrophages using light microscopy. In some experiments TRAM-34 (10 µM, Tocris Biosceince, UK) was added to the cell culture during macrophage differentiation to assess the effect of Kcnn4 blockade on macrophage multinucleation and MGC formation. Bone marrow-derived osteoclasts were generated from four-to twelve-week old Kcnn4 +/+ and Kcnn4 -/-mice as previously described (Cui et al., 2007) . Bone marrow cells were isolated, mechanically dissociated and cultured at a density of 1.33 x 10 6 cells per cm 2 in a-MEM containing 10% heat inactivated FBS, 100 units/ml penicillin-streptomycin (Invitrogen, Carlsbad, CA), 1% MEM vitamins, 1 mM glutamine, and 5 to 30 ng/ml M-CSF (R&D, Minneapolis, MN). RANKL (R&D) was added at a concentration of 7 or 40 ng/ml.
Culture medium was refreshed every three days. At the end of the culture, cells were fixed and reacted for tartrate-resistant acid phosphatase according to the supplier's directions.
TRAP-positive cells with 3 nuclei or more were counted as osteoclasts as previously described (Li et al., 2005) . Human monocyte derived macrophages were differentiated from buffy coats from healthy donors using gradient separation (Histopaque 1077, Sigma) and adhesion purification. Following Histopaque separation, peripheral blood mononuclear cells were re-suspended in RPMI (Life Technologies) and monocytes were purified by adherence for 1h at 37ºC, 5% CO 2 . The monolayer was washed 6 times with HBSS to remove nonadherent cells and monocytes were matured for 5 days in RPMI containing 100 ng/ml M-CSF (PeproTech, UK). Macrophage purity was confirmed by immunohistochemical assessment of CD68 and > 99% cells were CD68+. In some experiments human peripheral blood monocytes were obtained from AllCells LLC (Emeryville, CA). Human osteoclasts were generated from normal peripheral blood monocytes or positively selected normal peripheral blood CD14+ cells (AllCells, Emeryville, CA). Peripheral blood monocytes were isolated using Ficoll-Paque and cultured at a concentration of 3 x 10 6 cells/ml in low glucose DMEM supplemented with 10% fetal bovine serum (FBS; Gemini Bio-Products, NC), recombinant human M-CSF (20 ng/ml) and recombinant human RANKL (10 ng/ml). The medium was refreshed twice a week. At the end of the culture, the cells were fixed and reacted for tartrate-resistant acid phosphatase according to the supplier's directions. TRAP-positive cells with 3 nuclei or more were counted as osteoclasts.
eQTL analysis, network inference and cell type enrichment analysis
A transcript was designated as an eQTL when it mapped with a probability of 0.8 to a genomic region of less than 10 Mb. When multiple SNPs are located within the 10 Mb window, we referred to the SNP with the best marginal probability in that region as the associated SNP. We defined eQTL hotspots as SNPs linked to a significant over- The network shown in Figure 1C was built by first extracting gene expression from the 184 genes of the network (190 transcripts) and adjusting the gene expression for the effect of cisregulatory SNPs. R package minet was used to compute the mutual information between all pairs of gene as well as between all pair of genes and the chromosome 9 locus SNP, and ARACNE (Basso et al., 2005) was used to remove indirect edges from the network. Cell type enrichment analysis was performed using the Mouse GNF1M Gene Atlas data (GSE1133), containing expression from 78 tissues and cell types. Log transformed normalized expression was used and for each gene g and cell type c, a Z-score was computed to measure the relative overexpression of gene g in cell type c compared to other cell types. Each Z-score was then assigned a P-value for significance of the overexpression assuming normal distribution of the Z-scores. Finally, for each cell type, enrichment of the network was computed by counting the number of genes with a significant P-values at a marginal 0.05 level, inside and outside of the network and using an hypergeometric test for enrichment.
LPS-induced calvarial bone resorption assay
To assess osteoclast formation and activity in vivo, we administered a single local subperiosteal calvarial injection of LPS (25 µg in 2 µl; Escherichia coli O55:B5, Sigma
Chemical, St. Louis, MO) to 8-week-old male and female wild type and Kcnn4 -/-mice that were sacrificed 5 days later. Because the angle of the needle is kept fixed during the injection, the osteoclast pits tend to remain in the vicinity of the injected site. Animals were checked daily for the five-day duration of the experiment, including weekends and holidays, when applicable. Those animals showing evidence of pain, were administered analgesics based on consultation with a veterinarian. Calvariae were subjected to microCT analysis, and resorbed areas were quantified using ImageJ software (NIH, Bethesda, MD). All procedures were approved by the Yale University Institutional Animal Care and Use Committee.
Measurement of bone turnover markers
Serum samples were obtained from Kcnn4 +/+ and Kcnn4 -/-mice at sacrifice in control and following CAIA and were stored at −80 °C. N-terminal propeptide of type 1 procollagen (P1NP) and C-terminal cross-linked telopeptide of type I collagen (CTX) levels were determined by enzyme immunoassay using IDS kits AC-33F1 and AC-06F1, respectively (Immunodiagnostic Systems).
RNA-seq library preparation and data analysis in primary macrophages
Total RNA was extracted from WKY macrophages (+/-TRAM-34, 10µM) using Trizol (Invitrogen) according to manufacturer's instructions with an additional purification step by on-column DNase treatment using the RNase-free DNase Kit (Qiagen) to ensure elimination of any genomic DNA. The integrity and quantity of total RNA was determined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific) and Agilent 2100 Bioanalyzer (Agilent Technologies). 1µg of total RNA was used to generate RNA-seq libraries using
TruSeq RNA sample preparation kit (Illumina) according to the manufacturer's instructions.
Briefly, RNA was purified and fragmented using poly-T oligo-attached magnetic beads using two rounds of purification followed by the first and second cDNA strand synthesis. Next, cDNA 3' ends were adenylated and adapters ligated followed by 10 cycles of library amplification. Finally, the libraries were size selected using AMPue XP Beads (Becmkan Coulter) purified and their quality was checked using Agilent 2100 Bioanalyzer. Samples were randomized to avoid batch effects and libraries were run on a single lane per sample of the HiSeq 2000 platform (Illumina) to generate 75bp paired-end reads. RNA-seq reads were then aligned to the rn4 reference genome using tophat 2 and non-uniquely aligned reads where discarded leading to coverage of ~40M reads and 35M uniquely mapped reads. Gene level read counts were computed using HT-Seq and genes with less that 10 aligned reads across all samples were discarded prior to analysis leading to 15,155 genes. Differential expression analyses between the two groups were carried out using edgeR and using a 5%
FDR to call significant differentially expressed genes. Cell type enrichment analysis was performed using the Mouse GNF1M Gene Atlas data (GSE1133), containing expression from 78 tissues and cell types. Log transformed normalized expression was used and for each gene g and cell type c, a Z-score was computed to measure the relative overexpression of gene g in cell type c compared to other cell types. Each Z-score was then assigned a P-value for significance of the over-expression assuming normal distribution of the Z-scores. For each cell type, enrichment of the set of differentially expressed genes was computed by counting the number of genes with significant P-values at a marginal 0.05 level, inside and outside of the set of differentially expressed genes and using an hypergeometric test for enrichment.
siRNA and qRT-PCR
On day 5 of culture, WKY BMDMs were replated in six-well plates (1x10 6 cells per well) in DMEM (Invitrogen) overnight and transfected for 48 hours with siGENOME SMARTpool for either human or rat Trem2, and rat Treml1, Trem1, D3ZDX3_Rat (100 nM, Dharmacon)
or siGENOME non-targeting siRNA pool as the scrambled control siRNA using Dharmafect 1 (1:50, Dharmacon) as a transfection reagent in OPTIMEM medium (Invitrogen). For human monocytes-derived macrophages (MDMs), cells were incubated on day 5 of cluture with either human TREM2 siRNA or siGENOME non-targeting siRNA pool. The siRNA sequences used in the siGENOME SMARTpool for all transcripts are available upon request.
All qRT-PCRs were performed with an ABI 7900 Sequence Detection System (Applied Biosystems, Warrington, UK). A two-step protocol was used beginning with cDNA synthesis with iScript select (Bio-Rad) followed by PCR using SYBR Green Jumpstart Taq Ready Mix (Sigma). A total of 10ng of cDNA per sample was used. All samples were amplified using a set of 4 biological replicates with three technical replicates used per sample in the PCR analysis. Sequence detection software (SDS) version (Applied Biosystems) was used to obtain the Ct values. Results were analysed using the comparative Ct method and each sample was normalised to the reference gene Hprt, to account for any cDNA loading differences. The primer sequences are available upon request.
Histomorphometric analysis of the bone
Histomorphometry was performed 0.25 mm proximal to the growth plate using Osteomeasure 
Scoring and histopathological evaluation of collagen antibody-induced arthritis (CAIA)
The scoring system for CAIA was 0 = normal; 1 = erythema and edema in 1-2 digits; 2 = erythema and edema in >2 digits or mild erythema and edema, usually in the ankle joint; 3 = moderate erythema and edema encompassing the tarsal joint; 4 = severe erythema and edema encompassing the tarsal and metatarsal joint. This analysis was completed by Bolder BioPath (Boulder, Co). Formalin fixed joints (right and left fore and hind paws, both ankles and both knees) were decalcified in 5% formic acid for 2-3 days; tissues were trimmed, processed for paraffin embedding, sectioned at 8 µm and stained with toluidine blue. Both hind paws, both fore paws, and both knees were embedded and sectioned in the frontal plane while ankles were sectioned in the sagittal plane or ankles may be sectioned with hind paws in the frontal plane. All sections were scored without knowledge of the treatment groups. Groups were later identified as follows. When scoring paws or ankles from mice with arthritic lesions, severity of changes as well as number of individual joints affected were recorded. When only 1-3 joints of the paws or ankles out of a possibility of numerous metacarpal/metatarsal/digit or tarsal/tibio-tarsal joints were affected, an arbitrary assignment of a maximum score of 1, 2 or 3 for parameters below was given depending on severity of changes. If more than 3 joints were involved, the criteria below were applied to the most severely affected/majority of 
Calcium oscillations and electrophysiology
Bone marrow-derived macrophages isolated from Kcnn4 +/+ and Kcnn4 -/-mice were plated on 12-mm diameter coverglass that were placed in 24-well dishes. Cells were cultured in the presence of M-CSF (25 ng/ml) supplemented or not with RANKL (10 ng/ml). Oscillations were recorded 3 days later. Cells were incubated for 30 minutes at 30°C in loading solution (115 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM HEPES, and 10 mM glucose, pH 7.42) supplemented with 5 µM Fura-2/AM (Invitrogen). Fura-2 fluorescent images were analyzed using an inverted microscope (ECLIPSE TE300, Nikon) and a video image analysis system (Argus-50/CA, Hamamatsu Photonics) with excitation filters at 340 ±10 and 380 ± 10 nm, a dichroic beam splitter at 400 nm, and a bandpass emission filter at 510-550 nm. The recording solution contained 115 mM NaCl, 5.4 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 20 mM HEPES, and 10 mM glucose, pH 7.42. Data are presented as mean ± standard error of the mean (SEM) and statistical significance was determined using the Student's t-test.
Electrophysiology
For electrophysiology, macrophages plated on 12-mm diameter coverslips were transferred to a recording chamber and superfused (~1 ml/min) with external solution: 145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 2.5 mM Glucose, pH 7.4. Pipettes had a resistance of 3-9 MΩ when filled with internal solution: 120 mM KCl, 2 mM MgCl2, 10 mM HEPES, 20 mM glucose, 10 mM EGTA, pH 7.3. To achieve a free internal Ca PClamp9 software (Axon Instruments, CA) were used for recordings (2 kHz low-pass filtered; 5 kHz sampling rate). Cells were maintained at a holding potential of -60 mV.
Voltage steps from -100 mV to + 80 mV (400 ms) and voltage ramps (-140 mV to +120 mV over 200 ms) were applied to generate current / voltage plots in Clampfit 9.0 (Axon Instruments, CA).
Immunohistochemistry and Immunofluorescence
For ED-1 (AbD Serotec, Oxford, UK) immunostaining, formalin-fixed, paraffin-embedded rat tissues were microwaved in sodium citrate buffer for antigen retrieval. Following consecutive blocking steps (peroxide block for 15 min, 10% goat serum block for 15 min, followed by a 10% milk block for 15 min), sections were incubated with the primary antibody ED-1 (1:500) and the slides left for 1 h at room temperature. The slides were then washed and incubated in the polymer-HRP (Dako mouse EnVision kit, Dako, Denmark) for 30 min at room temperature. Staining was visualized using DAB (Dako EnVision kit) and sections counterstained with hematoxylin, dehydrated, and mounted with cover slips. For visualization of the acting cytoskeleton and nuclei, cells were fixed in 4% paraformaldehyde (PFA) for 20 minutes at room temperature and stained with rhodamine-phalloidin (Molecular Probes, Eugene, OR, USA) and 4′,6-diamidino-2-phenylindole (DAPI; Sigma ) as described (MacLauchlan et al., 2009 ).
Western Blotting
After four to seven days of culture, osteoclasts were serum-starved for three to four hours and stimulated with the indicated reagents. The cells were then lysed in Laemmli sample buffer supplemented with protease inhibitors (cOmpleteTM protease inhibitor tablets; Roche Molecular Biochemicals), sodium fluoride, and a phosphatase inhibitor cocktail II (Roche).
The lysates were sonicated and resolved by SDS-PAGE, transferred to PVDF membranes, and subjected to immunoblotting with appropriate primary and secondary antibodies. The probed proteins were detected using SuperSignal West Femto Cheluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL).
Statistical Analysis
Unless otherwise stated, data represent the mean ± one standard deviation (SD). Treatment groups were compared using the analysis of variance. Unless otherwise stated, pairwise comparison p-values between the treatment groups were adjusted using Tukey multiple comparison procedure. Statistical significance was declared if the two-sided p-value is < 0.05.
